Published in Gastroenterology on April 01, 2006
The Effect and Mechanism of Acupuncture on Functional Dyspepsia | NCT02358486
Pinaverium Bromide in Post-cholecystectomy Sphincter of Oddi Dysfunction | NCT02833103
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis | NCT02692495
Prevention of Colic With the Probiotic Lactobacillus Reuteri | NCT02577133
Ghrelin and Gastric Emptying in Children With Functional Dyspepsia (GHR) | NCT01591174
An Assessment of Cognitive Function in Irritable Bowel Syndrome | NCT01304355
Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2012) 2.60
Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther (2013) 2.26
Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders. Neurogastroenterol Motil (2015) 1.99
Diffusion tensor imaging detects microstructural reorganization in the brain associated with chronic irritable bowel syndrome. Pain (2013) 1.77
Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol (2009) 1.76
The current prevalence of irritable bowel syndrome in Asia. J Neurogastroenterol Motil (2010) 1.74
Defective leukocyte GM-CSF receptor (CD116) expression and function in inflammatory bowel disease. Gastroenterology (2011) 1.73
Global Epidemiology of Campylobacter Infection. Clin Microbiol Rev (2015) 1.73
Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol (2007) 1.57
Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors. Autism Res (2012) 1.55
Genomic and clinical effects associated with a relaxation response mind-body intervention in patients with irritable bowel syndrome and inflammatory bowel disease. PLoS One (2015) 1.52
Food allergy in adults: an over- or underrated problem? Dtsch Arztebl Int (2008) 1.50
Central pain mechanisms in chronic pain states--maybe it is all in their head. Best Pract Res Clin Rheumatol (2011) 1.46
Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years. J Crohns Colitis (2015) 1.44
Vitamin D status in pediatric irritable bowel syndrome. PLoS One (2017) 1.38
Functional Gastrointestinal Disorders Diagnosed by Rome III Questionnaire in Korea. J Neurogastroenterol Motil (2011) 1.36
Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey. Dig Dis Sci (2011) 1.35
Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan. J Gastroenterol (2009) 1.32
Text messaging: an innovative method of data collection in medical research. BMC Res Notes (2010) 1.32
Ehlers-danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder with mucocutaneous, articular, and systemic manifestations. ISRN Dermatol (2012) 1.32
Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea. Am J Gastroenterol (2016) 1.32
Functional bowel disorders in Iranian population using Rome III criteria. Saudi J Gastroenterol (2010) 1.30
Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther (2009) 1.28
The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III. J Neurogastroenterol Motil (2010) 1.24
Classification and diagnosis of patients with medically unexplained symptoms. J Gen Intern Med (2007) 1.23
A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology (2011) 1.22
Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J Gastroenterol (2006) 1.21
Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide. Aliment Pharmacol Ther (2013) 1.21
Current status of functional gastrointestinal evaluation in clinical practice. Singapore Med J (2015) 1.19
Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol (2010) 1.18
Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs Arch Pharmacol (2008) 1.18
Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog (2010) 1.17
Prevalence and predictive factors of fecal incontinence. J Neurogastroenterol Motil (2012) 1.15
Post-infectious irritable bowel syndrome. World J Gastroenterol (2009) 1.15
Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther (2010) 1.14
Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications. J Physiol Pharmacol (2009) 1.13
The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes (2012) 1.12
Patients with chronic visceral pain show sex-related alterations in intrinsic oscillations of the resting brain. J Neurosci (2013) 1.11
Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS). BMC Gastroenterol (2007) 1.10
Irritable bowel syndrome: a clinical review. World J Gastroenterol (2014) 1.10
The gut microbiota and irritable bowel syndrome: friend or foe? Int J Inflam (2012) 1.09
Lack of Association Found between Helicobacter pylori Infection and Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Retrospective Study. Gastroenterol Res Pract (2016) 1.08
Probiotic supplementation decreases intestinal transit time: meta-analysis of randomized controlled trials. World J Gastroenterol (2013) 1.07
Pathophysiological and psychosocial study in patients with functional vomiting. J Neurogastroenterol Motil (2010) 1.06
Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress. Aliment Pharmacol Ther (2008) 1.06
Recent insights into digestive motility in functional dyspepsia. J Gastroenterol (2006) 1.05
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05
Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation. Gut (2011) 1.04
Sustained self-regulation of energy intake. Loss of weight in overweight subjects. Maintenance of weight in normal-weight subjects. Nutr Metab (Lond) (2010) 1.04
Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World. J Neurogastroenterol Motil (2015) 1.04
Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. J Gastroenterol (2012) 1.03
Neuropathophysiology of functional gastrointestinal disorders. World J Gastroenterol (2007) 1.02
Prevalence of functional dyspepsia and its subgroups in patients with eating disorders. World J Gastroenterol (2012) 1.02
Main ion channels and receptors associated with visceral hypersensitivity in irritable bowel syndrome. Ann Gastroenterol (2014) 1.02
Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application. J Gastroenterol (2013) 1.02
Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterol (2016) 1.02
Irritable Bowel Syndrome in Iran: SEPAHAN Systematic Review No. 1. Int J Prev Med (2012) 1.01
Development and Validation of the Korean Rome III Questionnaire for Diagnosis of Functional Gastrointestinal Disorders. J Neurogastroenterol Motil (2013) 1.01
Development, Translation and Validation of Enhanced Asian Rome III Questionnaires for Diagnosis of Functional Bowel Diseases in Major Asian Languages: A Rome Foundation-Asian Neurogastroenterology and Motility Association Working Team Report. J Neurogastroenterol Motil (2015) 1.01
Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J Gastroenterol (2014) 1.00
Anti-enteric neuronal antibodies and the irritable bowel syndrome. J Neurogastroenterol Motil (2012) 0.98
Epidemiology characteristics of constipation for general population, pediatric population, and elderly population in china. Gastroenterol Res Pract (2014) 0.98
Methanogens, methane and gastrointestinal motility. J Neurogastroenterol Motil (2013) 0.97
A role for corticotropin-releasing factor in functional gastrointestinal disorders. Curr Gastroenterol Rep (2009) 0.97
Diagnosis and management of irritable bowel syndrome in adults in primary care: summary of NICE guidance. BMJ (2008) 0.96
The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes (2014) 0.96
Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome. Surg Endosc (2011) 0.95
Primary Care Management of Chronic Constipation in Asia: The ANMA Chronic Constipation Tool. J Neurogastroenterol Motil (2013) 0.95
A school-based study with Rome III criteria on the prevalence of functional gastrointestinal disorders in Chinese college and university students. PLoS One (2013) 0.95
Overlap in patients with dyspepsia/functional dyspepsia. J Neurogastroenterol Motil (2014) 0.94
Pattern of irritable bowel syndrome and its impact on quality of life in primary health care center attendees, Suez governorate, Egypt. Pan Afr Med J (2011) 0.94
Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings. Curr Gastroenterol Rep (2014) 0.94
Median arcuate ligament syndrome in the pediatric population. J Pediatr Surg (2013) 0.93
Sex and disease-related alterations of anterior insula functional connectivity in chronic abdominal pain. J Neurosci (2014) 0.93
Autonomic response to a visceral stressor is dysregulated in irritable bowel syndrome and correlates with duration of disease. Neurogastroenterol Motil (2013) 0.93
Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet. World J Gastroenterol (2014) 0.93
Regional neuroplastic brain changes in patients with chronic inflammatory and non-inflammatory visceral pain. PLoS One (2014) 0.92
Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients. World J Surg (2010) 0.92
Dyspepsia in Iran: SEPAHAN Systematic Review No. 3. Int J Prev Med (2012) 0.92
Exercise challenge in Gulf War Illness reveals two subgroups with altered brain structure and function. PLoS One (2013) 0.92
Hysterectomy does not cause constipation. Dis Colon Rectum (2008) 0.91
Influence of acupuncture stimulation on cerebral network in functional diarrhea. Evid Based Complement Alternat Med (2013) 0.91
Effects of Kampo on functional gastrointestinal disorders. Biopsychosoc Med (2014) 0.91
STW 5 (Iberogast®)--a safe and effective standard in the treatment of functional gastrointestinal disorders. Wien Med Wochenschr (2012) 0.91
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease. Mov Disord (2009) 0.90
Translation and validation of the Nepean Dyspepsia Index for functional dyspepsia in China. World J Gastroenterol (2009) 0.90
Impact of sleep disorders, quality of life and gastric emptying in distinct subtypes of functional dyspepsia in Japan. J Neurogastroenterol Motil (2013) 0.89
Analysis of Gastric and Duodenal Eosinophils in Children with Abdominal Pain Related Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil (2016) 0.89
Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments. World J Gastroenterol (2014) 0.89
The efficacy and safety study of electro-acupuncture for severe chronic functional constipation: study protocol for a multicenter, randomized, controlled trial. Trials (2013) 0.89
Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study. Glob Adv Health Med (2014) 0.89
Ghrelin and functional dyspepsia. Int J Pept (2010) 0.88
Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. World J Gastroenterol (2012) 0.88
Corticotropin-releasing hormone receptor 1 gene variants in irritable bowel syndrome. PLoS One (2012) 0.88
Frequency of abnormal fecal biomarkers in irritable bowel syndrome. Glob Adv Health Med (2014) 0.88
Acupuncture as a treatment for functional dyspepsia: design and methods of a randomized controlled trial. Trials (2009) 0.88
New treatments for irritable bowel syndrome in women. Womens Health (Lond Engl) (2008) 0.88
Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc (2014) 0.88